Loading...
XHKG
3309
Market cap260mUSD
Dec 05, Last price  
1.66HKD
1D
-1.19%
1Q
-14.87%
IPO
-77.41%
Name

C-Mer Eye Care Holdings Ltd

Chart & Performance

D1W1MN
XHKG:3309 chart
P/E
P/S
1.06
EPS
Div Yield, %
Shrs. gr., 5y
2.85%
Rev. gr., 5y
27.13%
Revenues
1.91b
-0.56%
156,472,000198,851,000248,659,000311,228,000429,374,000576,209,000699,545,0001,112,577,0001,731,903,0001,923,964,0001,913,162,000
Net income
-135m
L
22,361,00038,357,00046,887,00040,127,00042,571,00041,435,000-6,246,00021,861,000-21,875,00061,998,000-135,163,000
CFO
283m
-21.61%
42,606,00050,545,00053,497,00065,483,99940,904,000140,555,000104,032,000148,414,000191,858,000361,154,000283,120,000
Dividend
Jun 27, 20250.02 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates eye and surgery centers, and satellite clinics that provide cataract and intraocular lens implant, refractive correction, corneal and external eye disease, glaucoma, vitreo-retinal disease, oculoplastic and orbital disease, and squint and pediatric ophthalmology services. It also sells vision aid and pharmaceutical products, as well as dental services. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.
IPO date
Jan 15, 2018
Employees
2,115
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT